Jack Du has 3+ years of experience working with Brown Investment Group and 2+ years as an investment analyst. Anthony Battle is a CERTIFIED FINANCIAL PLANNER™ professional. He earned the Chartered ...

Prohibiting percentage-based remuneration bars PBMs and broadly defined affiliates from monetizing rebates, data fees, or administrative fees linked to WAC/list price in Part D. Elevating CMS ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund. Articles in this topic offer timely ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Despite bipartisan support, a last-ditch effort to pass a ...

On Feb. 3, 2026, President Donald Trump signed into law the Consolidated Appropriations Act, 2026 (CAA 2026), a sweeping piece of legislation including provisions that will substantially impact ...

The conclusion of the longest government shutdown in history and rising political acrimony rightly receives a great deal of attention but this focus makes it easy to overlook areas where beneficial ...

An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly excessive fees paid by ERISA health plan sponsors (in their fiduciary ...

The law requires PBMs that provide services to group health plans (i.e., ERISA-governed fully insured and self-funded plans) to comply with new requirements taking effect in 2028-2029, including: 100% ...

Medicare Part D PBM compensation is delinked from rebates and list prices, moving toward flat administrative fees intended to reduce rebate-driven incentive distortions. Enhanced semiannual reporting ...

As greater scrutiny envelops the largest pharmacy benefit management companies, one thing is clear: They are not going to give up without a fight. And in that existential battle, they just notched a ...